Andrew Sneddon
Chairman, Non-Executive Director
Immunology
TGR BioSciences
Australia
Biography
Andrew joined the TGR Board in February 2008 following retirement from his position as a Partner at PricewaterhouseCoopers (PWC). In his PWC role, Andrew led the technology practise for a period of time and specialised in fast growth and emerging technology companies working with many companies from start ups to successful global corporations. In more recent years he was the partner leading the firm’s Australian Life Sciences Practice. Andrew has extensive experience in a wide range of technical areas including mergers and acquisitions, business and strategic planning, audit, valuation, capital raising and stock exchange listings on the Australian, NASDAQ and London Stock Exchanges. He has worked across a broad range of industries and is currently a Non Executive Director at ClearView Wealth Limited, Innate Immunotherapeutics Limited and the chairman of ServiceRocket Inc, InterAcct Solutions Pte and Elastagen Pty Ltd. He is also a member of the Audit and Compliance Committees of the Crescent Capital Private Equity Funds.
Research Interest
Immunology
